The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic Requirements in Spine Surgery Patients
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
In this study the investigators plan to examine the perioperative use of sufentanil
sublingual (SL) in the analgesic regimen for spine surgery, one of the most common surgeries
performed in the US. Patients undergoing spinal fusion surgery often experience severe pain
during the first three postoperative days. Currently, no data are available for this patient
population which routinely experiences moderate to severe acute pain. The investigators will
analyze whether sufentanil SL is associated with lower opioid consumption, number of fentanyl
boluses given, post-anesthesia care unit and hospital length of stay, side effects of opioid
use (i.e., nausea, vomiting, constipation), and hospitalization costs (i.e.,
pharmacoeconomics).